Evidence map›Paper›PMID 18521956›Full record

ArticleEuropean journal of immunology2008

Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.

Yong Zhu Jin, Brian D Thompson, Zho Yan Zhou, Yineng Fu, Lutz Birnbaumer, Mei X Wu

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yong Zhu JinWellman Center of Photomedicine, Massachusetts General Hospital, and Department of Dermatology, Harvard Medical School, Boston, MA, USA.
Brian D Thompson
Zho Yan Zhou
Yineng Fu
Lutz Birnbaumer
Mei X Wu
Harvard University · USBeth Israel Deaconess Medical Center · USMassachusetts General Hospital · USNational Institute of Environmental Health Sciences · US

Funding

DERMATOLOGY TRAINING GRANTT32AR007098 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI THOMAS S. KUPPER · 1986 to 2026
$8.1M
Transmembrane Signaling MechanismsZIGES101643 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BIRNBAUMER, LUTZ · 2009 to 2010
$5.3M
Autoimmunity in IEX-1- transgenic miceR01AI050822 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2003 to 2006
$1.3M
IEX-1 in bridge of innate to adaptive immune responses to memory T cellsK02AI070785 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WU, MEI X · 2006 to 2010
$531k
NIAID NIH HHS AI 050822NIAID NIH HHS AI 070785NIAID NIH HHS K02 AI070785NIAID NIH HHS R01 AI050822NIAMS NIH HHS T32 AR007098NIAMS NIH HHS T32 AR 07098-31
6 · The paper itself

Abstract

This study delineates specific functions of Galphai2 and Galphai3 in T cell mobilization during the development of graft-versus-host disease (GVHD) and reveals reciprocal effects of these two G proteins on the onset and morbidity of the disease. A deletion of Galphai2 hampered trafficking of pathogenic T cells from secondary lymphoid tissues to inflammatory sites and sufficiently prevented GVHD. In contrast, a severer disease was induced in mice adoptively transferred with Galphai3-deficient T cells than those mice transferred with wild-type T cells. In agreement with this, pathogenic Galphai2(-/-) T cells displayed a defect in response to CXCL10, CXCL11, and CCL5, whereas lack of Galphai3 augmented T effector cell chemotaxis induced by CXCL10 and CXCL11 and resulted in their preference of homing to the liver and colon. Absence of either Galphai also abrogated sphingosince-1-phosphate (S1P)-mediated inhibition of T cell chemokinesis and facilitated T cell homing and expansion in the spleen and mesenteric lymph nodes at the early phase of GVHD development, which is another key determinant in the severity and early onset of the disease in the mice infused with Galphai3(-/-) T cells. These observations underscore interplay between Galphai2 and Galphai3 and potentially provide a novel strategy to prevent GVHD by blocking T cell homing at early stages and T effector cell trafficking at later time points.

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChemokinesChemotaxis, LeukocyteColonFemaleGraft vs Host DiseaseGTP-Binding Protein alpha SubunitsLiverLymphoid TissueLysophospholipidsMiceMice, KnockoutMice, SCIDSphingosineChemokinesGTP-Binding Protein alpha SubunitsLysophospholipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID18521956
PMCPMC2586968
OpenAlexW2058200198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.